
Acrivon Therapeutics, Inc.
Acrivon Therapeutics, Inc. (ACRV)
WebsitePrice
Market cap
Next catalystExpected Q4 2026ACR-368 — ACR-368-201 · Phase 2 dataCompany release ↗
Cash
Chart & Events
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
History / paused
PreINDP1P2P3FilingApproved